To further investigate the clinicopathological features and prognostic values of NALT1 expression in CRC patients, 76 different TNM stages CRC tissues (ranging from stages I through IV, all of them had detailed clinical and follow-up information available) were evaluated. The gene discussed is NALT1; the disease is colorectal carcinoma.